EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Pediatric TAFRO syndrome: A multi‐institution case series illustrating clinical challenges and excellent outcomes

Amanda K Johnson, Sasidhar Goteti iD, Bar Devald, Shelby Mestnik, Taumoha Ghosh, Robin Williams, Elizabeth S Doughty, Michael A Linden, Amy Beckman iD, Todd Williams, Kelsey Richardson, Marie Martinelli

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.31234 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Amanda K Johnson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology/Oncology, University of Utah/Intermountain Health Primary Children's Hospital, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Castleman Disease, Thrombocytopenia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A rare lymphoproliferative disorder involving thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), renal dysfunction (R), and organomegaly (O), called TAFRO syndrome, was first reported in 2010. Considered a variant of idiopathic multicentric Castleman's disease, the recent discovery and rarity of this syndrome pose challenges to diagnosis and management. Herein, we review three pediatric cases, including an infant, that illustrate the heterogeneity of TAFRO syndrome. Despite differences in presentation and treatment responses, all patients experienced excellent outcomes. This multi‐institutional case series highlights the need to work toward earlier diagnosis and improved long‐term management recommendations for patients with TAFRO syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Castleman DiseaseThrombocytopeniaAdolescentFemaleHumansInfantMaleEdemaFeverSyndrome

Stichwörter der Autor:innen

Castleman's diseaseanemiafeverlymphoproliferative disordersorganomegaly (TAFRO) syndromerenal dysfunctionreticulin fibrosisthrombocytopenia

Autor:innen und Institutionen

  • Division of Pediatric Hematology/Oncology, University of Utah/Intermountain Health Primary Children's Hospital, Salt Lake City, Utah, USA.
  • Division of Pediatric Hematology/Oncology, University of Minnesota/M Health Fairview Masonic Children's Hospital, Minneapolis, Minnesota, USA.
  • Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
  • Department of Pathology, University of Minnesota/M Health Fairview Masonic Children's Hospital, Minnesota, Minneapolis, USA.
  • Department of Pathology, Oregon Health & Science University/Doernbecher Children's Hospital, Oregon, Portland, USA.
  • Division of Pediatric Nephrology, Oregon Health & Science University/Doernbecher Children's Hospital, Portland, Oregon, USA.

ORCID-Profile: Sasidhar Goteti, Amy Beckman

Zitieren

APA

Johnson, A. K., Goteti, S., Devald, B., Mestnik, S., Ghosh, T., Williams, R., Doughty, E. S., Linden, M. A., Beckman, A., Williams, T., Richardson, K., & Martinelli, M. (2024). Pediatric TAFRO syndrome: A multi‐institution case series illustrating clinical challenges and excellent outcomes. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31234

Vancouver

Johnson AK, Goteti S, Devald B, Mestnik S, Ghosh T, Williams R, et al. Pediatric TAFRO syndrome: A multi‐institution case series illustrating clinical challenges and excellent outcomes. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31234

BibTeX
@article{Johnson2024,
  author = {Johnson, Amanda K and Goteti, Sasidhar and Devald, Bar and Mestnik, Shelby and Ghosh, Taumoha and Williams, Robin and Doughty, Elizabeth S and Linden, Michael A and Beckman, Amy and Williams, Todd and Richardson, Kelsey and Martinelli, Marie},
  title = {Pediatric TAFRO syndrome: A multi‐institution case series illustrating clinical challenges and excellent outcomes},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.31234}
}
Kostenlos starten →